Search

Your search keyword '"Brown, Jacqueline"' showing total 4 results
Start Over Author "Brown, Jacqueline" Journal clinical genitourinary cancer
4 results on '"Brown, Jacqueline"'

1. Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy

Author

Nicaise, Edouard H., Schmeusser, Benjamin N., Ali, Adil, Midenberg, Eric, Palacios, Arnold R., Hartsoe, Blaise, Kearns, Ethan, Ambadi, Sriram, Patil, Dattatraya H., Joshi, Shreyas S., Narayan, Vikram M., Psutka, Sarah P., Nazha, Bassel, Brown, Jacqueline T., Ogan, Kenneth, Bilen, Mehmet A., and Master, Viraj A.

Published
2024
Full Text
View/download PDF

4. Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients

Author

Martini, Dylan J., Evans, Sean T., Liu, Yuan, Shabto, Julie M., Uner, Ogul E., Olsen, T. Anders, Brown, Jacqueline T., Russler, Greta Anne, Yantorni, Lauren, Caulfield, Sarah, Goldman, Jamie M., Nazha, Bassel, Harris, Wayne B., Master, Viraj A., Kucuk, Omer, Carthon, Bradley C., and Bilen, Mehmet Asim

Abstract

Full dose cabozantinib for metastatic renal cell carcinoma (mRCC) is 60 mg, but adverse events (AEs) may require dose reductions. Limited data exist comparing efficacy among cabozantinib doses. We compared AEs and clinical outcomes in mRCC patients treated with full vs. reduced starting cabozantinib dose.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results